SEC Filings

SEC Filings

Filing date	Description	Form	View
Jul 06, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-245663.pdf 0001193125-15-245663.rtf 0001193125-15-245663.xls
Jun 30, 2015	FWP	FWP	View HTML 0001193125-15-239859.pdf 0001193125-15-239859.rtf 0001193125-15-239859.xls
Jun 30, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-239857.pdf 0001193125-15-239857.rtf 0001193125-15-239857.xls
Jun 30, 2015	Registration of up to an additional 20% of securities for any offering registered on a S-3	S-3MEF	View HTML 0001193125-15-240152.pdf 0001193125-15-240152.rtf 0001193125-15-240152.xls
Jun 30, 2015	Form of prospectus filed in connection with primary offering of securities on a delayed basis	424B2	View HTML 0001193125-15-241199.pdf 0001193125-15-241199.rtf 0001193125-15-241199.xls
Jun 30, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-241487.pdf 0001193125-15-241487.rtf 0001193125-15-241487.xls
Jun 29, 2015	Form of prospectus filed in connection with primary offering of securities on a delayed basis	424B2	View HTML 0001193125-15-239110.pdf 0001193125-15-239110.rtf 0001193125-15-239110.xls
Jun 22, 2015	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-15-008539.pdf 0001181431-15-008539.rtf
Jun 08, 2015	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-15-051054.pdf 0001209191-15-051054.rtf
Jun 04, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-213489.pdf 0001193125-15-213489.rtf 0001193125-15-213489.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE